Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver

Diabetes

Volumn 59, Issue 1, 2010, Pages 215-218

  Stadler, Marietta ^a,b   Anderwald, Christian ^c   Pacini, Giovanni ^d   Zbýň, Štefan ^c   Promintzer Schifferl, Miriam ^c   Mandl, Martina ^c   Bischof, Martin ^c   Gruber, Stephan ^c   Nowotny, Peter ^c   Luger, Anton ^c   Prager, Rudolf ^a,b   Krebs, Michael ^c  

^a HIETZING HOSPITAL   (Austria)

^b Karl Landsteiner Institute for Endocrinology and Metabolism   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY PANCREAS TRANSPLANTATION; LIPID STORAGE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; BLOOD; BLOOD PRESSURE; DIABETIC NEPHROPATHY; DIET RESTRICTION; FOLLOW UP; HYPERINSULINISM; KIDNEY TRANSPLANTATION; LIVER; METABOLISM; MIDDLE AGED; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SKELETAL MUSCLE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; HYPERINSULINISM; INSULIN; KIDNEY TRANSPLANTATION; LIPIDS; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PANCREAS TRANSPLANTATION; REFERENCE VALUES;

EID: 77449156382     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0354     Document Type: Article

References (25)

1. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab 2005;7:621-632
2. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116
3. Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002;51:3025-3032
4. Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, Battezzati A, Secchi A, Del Maschio A, Luzi L. Insulin resistance, intramyo-cellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003;285:E1174-E1181
5. Bernroider E, Brehm A, Krssak M, Anderwald C, Trajanoski Z, Cline G, Shulman GI, Roden M. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes. J Clin Endocrinol Metab 2005;90:5559-5565
6. Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: a sign of impaired β-cell function? Diabetes Care 2006;29:1031-1038
7. Fasching P, Ratheiser K, Damjancic P, Schneider B, Nowotny P, Vierhapper H, Waldhäusl W. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:346-351
8. Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M. Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 2007;30:2375-2380
9. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679
10. Krebs M, Krssak M, Nowotny P, Weghuber D, Gruber S, Mlynarik V, Bischof M, Stingl H, Fü rnsinn C, Waldhäusl W, Roden M. Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 2001;86:2153-2160
11. Bischof MG, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman GI, Waldhäusl W, Roden M. Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes 2002;51:49-54
12. Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H. Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987;30:834-840
13. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007;133:496-506
14. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005;48:2615-2621
15. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Hä ring HU, Jacob S, Schick F. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 2001;45:179-183
16. Perseghin G, Caumo A, Sereni LP, Battezzati A, Luzi L. Fasting blood sample-based assessment of insulin sensitivity in kidney-pancreas-transplanted patients. Diabetes Care 2002;25:2207-2211
17. Osei K, Henry M, Ferguson R. Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients. Transplant Proc 1994;26:480-482
18. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001;16:829-835
19. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002;25:583-592
20. Katz H, Homan M, Velosa J, Robertson P, Rizza R. Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991;325:1278-1283
21. Petruzzo P, Laville M, Badet L, Lefrançois N, Bin-Dorel S, Chapuis F, Andreelli F, Martin X. Effect of venous drainage site on insulin action after simultaneous pancreas-kidney transplantation. Transplantation 2004;77:1875-1879
22. Rooney DP, Robertson RP. Hepatic insulin resistance after pancreas transplantation in type I diabetes. Diabetes 1996;45:134-138
23. Prager R, Wallace P, Olefsky JM. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 1987;36:607-611
24. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 1996;45:1594-1604
25. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 1998;47:523-529